{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:59:40Z","timestamp":1780059580246,"version":"3.54.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,5]]},"DOI":"10.7759\/cureus.106451","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T07:57:43Z","timestamp":1775375863000},"source":"Crossref","is-referenced-by-count":1,"title":["Ciprofloxacin-Induced Guillain-Barr\u00e9 Syndrome, Posterior Reversible Encephalopathy Syndrome, Hepatotoxicity, and Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Case Report"],"prefix":"10.7759","author":[{"given":"Khaled","family":"Zammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alghalya","family":"Al-Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Safan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boulenouar","family":"Mesraoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayane","family":"Melikyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-008636","article-title":"Ciprofloxacin-associated posterior reversible encephalopathy","volume":"2013","author":"Ali WH","year":"2013","unstructured":"Ali WH. Ciprofloxacin-associated posterior reversible encephalopathy. BMJ Case Rep. 2013, 2013:bcr2013008636. 10.1136\/bcr-2013-008636","journal-title":"BMJ Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2013.12.009","article-title":"Peripheral neuropathy and Guillain-Barr\u00e9 syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis","volume":"24","author":"Ali AK","year":"2014","unstructured":"Ali AK. Peripheral neuropathy and Guillain-Barr\u00e9 syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis. Ann Epidemiol. 2014, 24:279-85. 10.1016\/j.annepidem.2013.12.009","journal-title":"Ann Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0887","article-title":"Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy","volume":"76","author":"Morales D","year":"2019","unstructured":"Morales D, Pacurariu A, Slattery J, Pinheiro L, McGettigan P, Kurz X. Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy. JAMA Neurol. 2019, 76:827-33. 10.1001\/jamaneurol.2019.0887","journal-title":"JAMA Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000489303","article-title":"Severe acute axonal neuropathy induced by ciprofloxacin: a case report","volume":"10","author":"Popescu C","year":"2018","unstructured":"Popescu C. Severe acute axonal neuropathy induced by ciprofloxacin: a case report. Case Rep Neurol. 2018, 10:124-9. 10.1159\/000489303","journal-title":"Case Rep Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104786","article-title":"Fluoroquinolones suppress gluconeogenesis by inhibiting fructose 1,6-bisphosphatase in primary monkey hepatocytes","volume":"65","author":"Iguchi T","year":"2020","unstructured":"Iguchi T, Goto K, Watanabe K, et al.. Fluoroquinolones suppress gluconeogenesis by inhibiting fructose 1,6-bisphosphatase in primary monkey hepatocytes. Toxicol In Vitro. 2020, 65:104786. 10.1016\/j.tiv.2020.104786","journal-title":"Toxicol In Vitro"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and histopathologic features of fluoroquinolone-induced liver injury","volume":"9","author":"Orman ES","year":"2011","unstructured":"Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol. 2011, 9:517-23.e3. 10.1016\/j.cgh.2011.02.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013502457","article-title":"SIADH associated with ciprofloxacin","volume":"47","author":"Babar SM","year":"2013","unstructured":"Babar SM. SIADH associated with ciprofloxacin. Ann Pharmacother. 2013, 47:1359-63. 10.1177\/1060028013502457","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2006.01.004","article-title":"Posterior reversible encephalopathy and Guillain-Barr\u00e9 syndrome in a single patient: coincidence or causative relation?","volume":"109","author":"Van Diest D","year":"2007","unstructured":"Van Diest D, Van Goethem JW, Vercruyssen A, Jadoul C, Cras P. Posterior reversible encephalopathy and Guillain-Barr\u00e9 syndrome in a single patient: coincidence or causative relation?. Clin Neurol Neurosurg. 2007, 109:58-62. 10.1016\/j.clineuro.2006.01.004","journal-title":"Clin Neurol Neurosurg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.6.1365-a","article-title":"SIADH as the first symptom of Guillain-Barr\u00e9 syndrome","volume":"53","author":"Hoffmann O","year":"1999","unstructured":"Hoffmann O, Reuter U, Schielke E, Weber JR. SIADH as the first symptom of Guillain-Barr\u00e9 syndrome. Neurology. 1999, 53:1365. 10.1212\/wnl.53.6.1365-a","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omy042","article-title":"Guillain-Barr\u00e9 syndrome hyponatremia: is it SIADH or pseudohyponatremia?","volume":"2018","author":"Zemke AM","year":"2018","unstructured":"Zemke AM, Boles LH, Gillespie M, Viljoen JM. Guillain-Barr\u00e9 syndrome hyponatremia: is it SIADH or pseudohyponatremia?. Oxf Med Case Reports. 2018, 2018:omy042. 10.1093\/omcr\/omy042","journal-title":"Oxf Med Case Reports"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.233767","article-title":"SIADH and dysautonomia as the initial presentation of Guillain-Barr\u00e9 syndrome","volume":"83","author":"Ramanathan S","year":"2012","unstructured":"Ramanathan S, McMeniman J, Cabela R, Holmes-Walker DJ, Fung VS. SIADH and dysautonomia as the initial presentation of Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2012, 83:344-5. 10.1136\/jnnp.2010.233767","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2008.10.017","article-title":"Disturbance of cellular glucose transport by two prevalently used fluoroquinolone antibiotics ciprofloxacin and levofloxacin involves glucose transporter type 1","volume":"184","author":"Ge DT","year":"2009","unstructured":"Ge DT, Law PY, Kong SK, Ho YY. Disturbance of cellular glucose transport by two prevalently used fluoroquinolone antibiotics ciprofloxacin and levofloxacin involves glucose transporter type 1. Toxicol Lett. 2009, 184:81-4. 10.1016\/j.toxlet.2008.10.017","journal-title":"Toxicol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/324448-ciprofloxacin-induced-guillain-barr-syndrome-posterior-reversible-encephalopathy-syndrome-hepatotoxicity-and-syndrome-of-inappropriate-antidiuretic-hormone-secretion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T07:57:44Z","timestamp":1775375864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/324448-ciprofloxacin-induced-guillain-barr-syndrome-posterior-reversible-encephalopathy-syndrome-hepatotoxicity-and-syndrome-of-inappropriate-antidiuretic-hormone-secretion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.106451","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,5]]}}}